Saline Hypertonic in Preschoolers + CT

ClinicalTrials.gov ID: NCT02950883

Public ClinicalTrials.gov record NCT02950883. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 19, 2026, 1:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Saline Hypertonic in Preschoolers With Cystic Fibrosis and Lung Structure as Measured by Computed Tomography (CT)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess whether inhalation of 7% hypertonic saline (HS) twice daily for 48 weeks reduces structural lung disease as assessed by computed tomography (CT) in comparison with inhalation of 0.9% isotonic saline (IS) in preschool children (ages 3 to 6) with cystic fibrosis.

Study identification

NCT ID: NCT02950883
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2, Phase 3
Lead sponsor: University of Washington, the Collaborative Health Studies Coordinating Center; Other
Enrollment: 116 participants

Conditions and interventions

Conditions

Cystic Fibrosis

Interventions

Drug

Eligibility (public fields only)

Age range: 3 Years to 5 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 24, 2015 (Actual)
Primary completion: Dec 15, 2020 (Actual)
Completion: Jun 25, 2021 (Actual)
Last update posted: Mar 12, 2024

2015 – 2021

United States locations

U.S. sites: 7
U.S. states: 7
U.S. cities: 7

Facility	City	State	ZIP	Site status
Children's Hospital of Colorado	Aurora	Colorado	80045	—
Riley Hospital for Children	Indianapolis	Indiana	46202	—
Washington University School of Medicine	St Louis	Missouri	63110	—
University of North Carolina at Chapel Hill	Chapel Hill	North Carolina	27599	—
Oregon Health Sciences University	Portland	Oregon	97239	—
Children's Hospital of Pittsburgh of UPMC	Pittsburgh	Pennsylvania	15224	—
Seattle Children's Hospital	Seattle	Washington	98105	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02950883, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 12, 2024 · Synced Oct 19, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02950883 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →